Overview
Updated 14 Jul 2026
Robert Shafer, MD, is Professor (Research) of Medicine (Infectious Diseases and Geographic Medicine) and, by courtesy, of Pathology at Stanford University School of Medicine, Department of Medicine - Infectious Diseases and Geographic Medicine. The public record shows 377 publications with 25,467 citations (h-index 86), centered on HIV/AIDS drug development and treatment, HIV Research and Treatment, HIV/AIDS Research and Interventions. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 3 companies, 7 NIH-funded awards (1999–2026).
- Most recent indexed publication: 2026 · PloS one
- Top research focus: HIV/AIDS drug development and treatment
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 249.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure
Sponsor: University of California, San Francisco
InvestigatorPhase 4CompletedNCT00735072 - A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
InvestigatorCompletedNCT00000919
Industry payments
Updated 14 Jul 2026
3 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20231 payment
- GlaxoSmithKline, LLC.Program year20221 payment
- GlaxoSmithKline, LLC.Program year20212 payments
NIH funding
Updated 14 Jul 2026
7 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies.
Communications medicine
2026 - Emergent HIV-1 Drug Resistance in Randomized Trials of Contemporary Antiretroviral Regimens.
Clinical infectious diseases
2026
Most-cited worksby citation count (OpenAlex)
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
1000 Welch Rd Ste 202, Palo Alto, CA 94304
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Editorial & leadership rolesjournal and society appointments
- Faculty member
IAS-USA (International Antiviral Society-USA) HIV drug resistance education program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →iasusa.org ↗ - Principal investigator / director
Stanford HIV Drug Resistance Database (HIVDB.stanford.edu), a public resource for HIV drug resistance surveillance and genotypic test interpretation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗ - Technical director
Stanford University Hospitals Genotypic Antiretroviral Resistance Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗
Secondary affiliationsappointments beyond the home institution
- By-courtesy appointment
Department of Pathology, Stanford University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.stanford.edu ↗ - Member
Bio-X (Stanford interdisciplinary research institute)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biox.stanford.edu ↗ - Clinical practice
Stanford Health Care (Infectious Diseases)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →stanfordhealthcare.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/robert-shafer-md-f8a3a8a3
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Robert-Shafer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Heidenreich, MD
Stanford University
- 1,067
- publications
- 113
- h-index
- 7
- trials
Mark Pegram, MD
Stanford University
- 421
- publications
- 67
- h-index
- 11
- trials
Crystal Mackall, MD
Stanford University
- 333
- publications
- 75
- h-index
- 9
- trials
David Maron, MD
Stanford University
- 455
- publications
- 67
- h-index
- 4
- trials